Even though epilepsy is one of the most prevalent and debilitating neurological disorders, our knowledge of its precise pathogenesis and therapeutic rationale is limited. Sixty-five million individuals throughout the globe are living with epilepsy, which imposes a substantial burden in terms of disability, mortality, comorbidities, stigma, and expenses due to seizures. Significant progress has been made in the last decade toward a better understanding of the pathophysiological underpinnings of the illness and the variables that influence its prognosis. These developments have resulted in updated criteria and terminology for the diagnosis and categorization of epilepsy and new conceptual and operational definitions. However, while there has been a significant rise in antiepileptic medications in the last 20 years, around a third of patients still refuse to respond to conventional therapy and take non-conventional treatment. Furthermore, only a tiny percentage of drug-resistant patients get epilepsy surgery, despite the fact that more than half of those who undergo surgery experience permanent independence from seizures. This article aims to introduce readers to the clinical aspects of epilepsy by covering topics including diagnostic methods, risk factors, and treatment strategies, as well as the current scenario of epilepsy in Bangladesh.